Hosted on MSN10mon
Merck hits record high after FDA approves lung disease drugReuters reported that the drug will carry a list price of $14,000 per vial, and that Merck plans to bring Winrevair to market by end-April. PAH is caused by the constriction of arteries in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback